EQT has sold Spain-based Igenomix – a reproductive medicine and rare diseases diagnostics business – to listed Swedish market peer Vitrolife in a €1.25bn trade sale that will see EQT acquire a minority stake in Vitrolife.
EQT has sold Spain-based Igenomix – a reproductive medicine and rare diseases diagnostics business – to listed Swedish market peer Vitrolife in a €1.25bn trade sale that will see EQT acquire a minority stake in Vitrolife.